Cipher Pharma Q2 EPS Misses Estimate
Cipher Pharma reports Q2 EPS of $0.15, missing the $0.19 estimate
Cipher Pharma (TSX: CPH ) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.19 by 21.05 percent.
This is a 31.82 percent decrease over earnings of $0.22 per share from the same period last year.
The company reported quarterly sales of $12.067 million which missed the analyst consensus estimate of $13.606 million by 11.31 percent.
This is a 9.82 percent decrease over sales of $13.381 million the same period last year.